FDA Approved: SUMATRIPTAN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for a Sumatriptan succinate generic product from Aurobindo Pharma Limited under ANDA 078327. This action authorizes …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Sumatriptan succinate (Sumatriptan succinate)

Snippet

SUPPL AP for SUMATRIPTAN (SUMATRIPTAN SUCCINATE)